Skip to content
LauréoBetaPublic procurement intelligence
Settings
My account

PRODUITS IMMUNISANTS «VACCIN CONTRE HAEMOPHILUS INFLUENZAE B (HIB)»

Source: SEAO

SigmaSanté · Method not published · closed December 6, 2018 at 2:00 p.m., Quebec time

Facts

Published
November 1, 2018
Time to award
12 days after closingmedian, all notices: 26 d (over 119,539 notices)
how it's calculated — Time to award

Time to award — where the number comes from

The calculation
Calendar days between closing (December 6, 2018) and the first award date published for this notice (December 18, 2018): 12 days.
What goes in
For this notice, every dated award counts, whatever its status, and the earliest date is kept. The median across all notices only keeps the notices whose earliest dated winning award, neither cancelled nor unsuccessful, falls on or after the closing day — over 119,539 notices.
Distribution
Source
SEAO — Quebec open data · CC-BY 4.0 · data up to date as of October 4, 2026 · link to this detail
Method
0
Time to submit
35 days · computed between publication and closing
how it's calculated — Time to submit

Time to submit — where the number comes from

The calculation
Days between publication (November 1, 2018) and closing (December 6, 2018), rounded to the day: 35 days.
What goes in
The source publishes no duration for this notice: the number comes from its two dates. A gap of less than half a day, or a closing before publication, gives no window.
Source
SEAO — Quebec open data · CC-BY 4.0 · data up to date as of October 4, 2026 · link to this detail
Value
— not declared
Reference
Notice no. 2019-4724-00-01
UNSPSC
51201606Vaccin contre l'haemophilus influenzae
SEAO category
G21 — Fourniture et équipement médicaux et produits pharmaceutiques

SEAO, Données Québec · data as of October 4, 2026

Description

100%

SigmaSanté est un organisme à but non lucratif en matière d’approvisionnement en commun de biens et services agissant à titre de mandataire de la Direction générale adjointe de la protection de la santé publique du Ministère de la Santé et des Services sociaux du Québec (D.G.A.P.S.P.) a lancé l’appel d’offres portant le numéro 2019-4724-00-01 pour l’acquisition de PRODUITS IMMUNISANTS «VACCIN VACCIN CONTRE HAEMOPHILUS INFLUENZAE B (HIB)» L’entente à intervenir est d’une durée initiale de DEUX (2) ans avec des prix fermes et assortie d’UNE (1) option de renouvellement de DOUZE(12) mois selon les modalités prévues au Contrat. Pour être valides et considérées, les Soumissions doivent être adressées à SigmaSanté et reçues au plus tard 29 novembre 2018 à 14 :00 :00 heures, (l’heure de réception d’une Soumission est réputée être celle indiquée par l’horloge qui se trouve au bureau de réception des Soumissions). Les soumissionnaires sont tenus de prendre connaissance des exigences décrites aux documents d’appel d’offres. SigmaSanté ne s’engage pas à accepter ni la plus basse ni aucune des soumissions reçues. Elle se réserve en outre le droit de rejeter toutes les soumissions reçues, si elle le juge à propos, sans pour autant être tenue responsable ou faire l’objet d’une poursuite ou réclamation pour les frais ou pertes subis par les soumissionnaires. RESPONSABLE DU DOSSIER : Bertha Myrthil Courriel : (email on the official notice)

SEAO, Données Québec · data as of October 4, 2026

Precedents — this code at this buyer

Where do these figures come from?
reserved · subscriptionViews used up for this month: this block opens with an account.

Bidders

the source is silent — The source publishes no bidders for this notice.

The price to beat

the source is silent — The open dataset publishes no submitted amount for this public tender.

Contracting authority history — most recent awards

Where do these figures come from?
reserved · subscriptionViews used up for this month: this block opens with an account. Free with an account

Award

Winners and awarded amounts
YearWinnerValue
2018GlaxoSmithKline Inc.$555,750declared
Signed contracts and their end dates
ContractSignedEnd dateContract amount
1781594The signed contract exceeds the awarded amount by $92,226 — +16.6%. A gap is a fact, not a judgement: across 121,996 comparable pairs it exists in 62% of cases, and half of them are below the awarded amount.2018March 30, 2022$647,976declared

SEAO, Données Québec · data as of October 4, 2026

Documents

the source is silent — No document in the open dataset · SEAO notice

Similar open notices

the source is silent — No Québec notice still open under 51201606, nor in its class (512016) or its family (5120).

Cite this page
Permalink
https://www.laureo.ca/en/avis/ocds-ec9k95-1210748
Citation
Lauréo, “PRODUITS IMMUNISANTS «VACCIN CONTRE HAEMOPHILUS INFLUENZAE B (HIB)»”, SigmaSanté, notice no. 2019-4724-00-01, data as of October 4, 2026, from SEAO / Données Québec (CC-BY 4.0). https://www.laureo.ca/en/avis/ocds-ec9k95-1210748
Reuse
Figures and text reusable with attribution. SEAO documents are never redistributed: they are linked to their official source.
Report an error